Full-Time
Consultant - Patient & Brand Analytics
KMK Consulting, Inc.
201-500 employees
Pharma analytics and consulting services
No salary listed
Morris Plains, NJ, USA
In Person
 Biology & Biotech (1) |
|---|
Get referred to KMK Consulting, Inc.
See people who can refer or advise you
- At least 6 years of experience managing and hands-on delivering end-to-end Patient and Brand Analytics engagements.
- Strong experience working with patient-level datasets, especially in specialty pharma.
- Strong analytical and problem-solving skills.
- Excellent communication and stakeholder-management ability.
- Ability to work independently and influence decisions.
- Partner with stakeholders and translate business needs into data-driven insights.
- Present recommendations with confidence and clarity.
- Provide strategic input and challenge assumptions when needed.
- Oncology experience.
KMK Consulting, Inc. provides analytics and consulting for life sciences, focusing on pharma and biotech. Its offerings blend software and advisory services to improve planning, commercialization, and value demonstration across the product lifecycle, including Commercial Analytics, HEOR, RWE, Advanced Analytics, Market Research, and Data Services, with flexible delivery models (project work, SaaS, or on-site teams). Customers use KMK to optimize sales force effectiveness, design incentive programs, and generate evidence for drug approval and reimbursement. In 2026 KMK was acquired by Tredence to combine pharma expertise with AI and data engineering, expanding capabilities in research, development, supply chain, and commercial operations.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Morris Plains, New Jersey
Founded
2000
Get referred to KMK Consulting, Inc.
See people who can refer or advise you
Simplify's Take
What believers are saying
- Tredence targets healthcare and life sciences at 25% of revenue by 2028.
- June 22, 2026 deal expands KMK’s access to AI engineering and data engineering.
- Veeva ecosystem positioning strengthens KMK’s commercial analytics sales motion in 2026.
What critics are saying
- Tredence integration can dilute KMK’s boutique brand and trigger client churn by 2027.
- Heavy reliance on a few large pharma accounts exposes KMK to procurement pressure.
- If Tredence misses healthcare growth targets, KMK becomes a commoditized services bolt-on.
What makes KMK Consulting, Inc. unique
- June 2026 Tredence acquisition combines KMK’s biopharma domain depth with agentic AI.
- KMK worked with eight of the world’s top ten pharmaceutical companies.
- KMK spans RWE, HEOR, commercial analytics, and market research across lifecycle stages.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company News
/PRNewswire/ -- Tredence, the world's leading AI and data science solutions company, today announced the acquisition of KMK Consulting, a specialized analytics...